SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-023385
Filing Date
2004-02-13
Accepted
2004-02-13 17:06:52
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K DATED 12/31/2003 d10ka.htm 10-K/A 1414579
3 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES dex121.htm EX-12.1 28096
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 3638
5 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 2415
6 302 CERTIFICATION OF THE CEO dex311.htm EX-31.1 9039
7 302 CERTIFICATION OF THE CFO dex312.htm EX-31.2 9047
8 906 CERTIFICATION OF THE CEO & CFO dex32.htm EX-32 6420
  Complete submission text file 0001193125-04-023385.txt   1475458
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23272 | Film No.: 04600262
SIC: 2836 Biological Products, (No Diagnostic Substances)